Reliable identification of metastases – with Molecular Imaging

Information obtained with molecular imaging is critical for therapy planning, as the presence of metastases may result in a modification of the therapeutic decision. Combining advanced technologies of two imaging modalities, PET and CT, our Biograph system makes it possible to produce an image that reveals detailed anatomy and biological processes at the molecular level of internal organs and tissues from one single non-invasive diagnostic procedure – thus helping to identify distant metastases. In addition, PET•CT fused datasets provide important information for radiotherapy planning, since they provide more accurate delineation of viable tumors.

Data courtesy of the University of Tennessee, Knoxville, USA

What’s more, lymphoscintigraphy can be performed by our Symbia systems. Symbia S combines state-of-the-art SPECT image quality with unprecedented workflow automation and handles higher patient volume with ease. And our Symbia TruePoint SPECT•CT increases diagnostic confidence for localization of the sentinel node, due to the diagnostic CT component involved in the hybrid imaging study.

Images courtesy of Dr. Shahid Mahmood, Radiology Clinic Parkway Hospitals, Singapore, Singapore